Related Experiment Video
Updated: Jul 23, 2025
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.2K
Oestrogen-based therapies for menopausal symptoms.
1Poole Menopause Centre, University Hospitals Dorset, Poole UK.
Summary
Oestrogen therapies for menopausal symptoms offer various options. Choosing the right treatment requires understanding individual needs, pharmacokinetics, and potential risks versus benefits for optimal outcomes.
Area of Science:
- Reproductive Endocrinology
- Pharmacology
- Women's Health
Background:
- Menopausal symptoms significantly impact women's quality of life.
- Hormone replacement therapy, particularly oestrogen-based treatments, is a common management strategy.
- Understanding diverse oestrogen therapy options is crucial for effective symptom relief.
Purpose of the Study:
- To review dosing, regimens, pharmacokinetics, risks, and benefits of oestrogen-based therapies.
- To provide a comprehensive overview of available oestrogen treatments for menopausal symptoms.
Main Methods:
- Comprehensive literature review across multiple databases.
- Inclusion of randomized trials, observational studies, meta-analyses, and review papers.
Main Results:
- Systemic oestrogen preparations show comparable efficacy but differ in pharmacokinetics and risk profiles.
- Hepatic metabolism-sparing preparations may have lower risks but can face acceptability issues.
- Vaginal oestrogen treatments are equally effective and pose no identified health risks.
Conclusions:
- No single oestrogen treatment is suitable for all women.
- A variety of oestrogen therapies are available for menopausal symptom management.
- Clinicians should guide patients toward evidence-based, informed choices regarding oestrogen therapy.
Keywords:
oestrogen-based therapiesoral oestrogenrisks and benefitstransdermal oestrogenvaginal oestrogenMore Related Videos
Related Concept Videos
01:28Menopause
205
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
205
01:22Hormonal Regulation of the Menstrual Cycle
456
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
456
01:30Hormonal Control of the Ovarian Cycle
585
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
585
01:27Major Hormones and Their Functions
507
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
507
01:23Antidepressant Drugs: MAOIs and Other Agents
275
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
275
01:26Cholinergic Antagonists: Therapeutic Uses
780
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
780